Wednesday, January 14, 2026
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home Tags Innv

Tag: innv

Steven Boyd, Armistice Capital, Biotech Stock Review
Biotech News

Armistice Capital Voting on AYTU (AYTU) and Innovus (INNV) Merger.

Editor / Curator -
biotech stock review
Biotech News

Innovus (INNV) Gains 75% in Past Week.

Editor / Curator -
Biotech News

Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase...

Editor / Curator -
Biotech News

Innovus (INNV) New E-Commerce Store on Track for $3 million in...

Editor / Curator -
DIABASENS
All News

Diabasens® to Launch in Europe. Innovus (INNV).

Editor / Curator -
Biotech News

Innovus (INNV) in Silicon Review Interview.

Editor / Curator -
internet stock review
Conference Calls

Innovus (INNV) Conference Call Transcript.

Editor / Curator -
internet stock review
Conference Calls

Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.

Editor / Curator -
biotech stock review, innovus
All News

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Editor / Curator -
biotech stock review, zestra
Biotech News

Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for...

Editor / Curator -
12Page 1 of 2

Latest article

Y-Combinator | Top 10 Performing Portfolio Holdings

All News Editor / Curator -
Y Combinator, LLC (YC) is an US based technology startup accelerator and venture capital firm launched in March 2005, has incredibly been used to...

Society Pass (SOPA) Perking Up, Gains 169% in Last Trading Five Days.

2025 Watch List Editor / Curator -
For the record, we are not traders. And that 'not-something-moniker' dates back to 1995. So while it's nice to see it perking up, we...

Sekur Private Data (SKUR, SWISF) Inching Towards a Double!

Uncategorized Editor / Curator -
Sekur Private Data has been slowly working it's way higher, on a series of positive news events. Here are the headlines and short to...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.